Charles Elliott Sigal Buys $244K of Alnylam Pharmaceuticals Inc (ALNY) — SEC Form 4, Nov 12, 2026

Open-Market Net Purchase · SEC Form 4
+$243,600

Equity position changed by +46.4%

Reporting Owner
TXN 2026-11-10 · FILED 2026-11-12
Equity Position 5.05K sh 3,446 → 5,046
Equity Change +46.4% shares held after vs before
Insider Cluster 2 buying within 30 days — view cluster
Filing Lag 1 business day within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-11-12
Report Date
2026-11-12
Accession No.
0001178670-26-000087
Accepted At
2026-11-12 21:05 UTC
Reporting Owner
Name Relationship
Charles Elliott Sigal CIK 0001661908
Director
Charles Elliott Sigal at Alnylam Pharmaceuticals Inc Full insider history
Bought (12 mo) $243,600
Sold (12 mo) —
More from this insider at Alnylam Pharmaceuticals Inc
All filings by this insider at Alnylam Pharmaceuticals Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2026-11-10 P - Purchase 1,600 A $152.25 +$243,600 3,600 Indirect by Trust
Non-Derivative Holdings
Title Shares Held Ownership
Common Stock 1,446 Direct
Footnotes (1)
F1
Shares held by Sigal Family Investments, LLC, of which the reporting person is Managing Member. Show more
5%+ Holders · 13D/G 6 filers
Other insiders at Alnylam Pharmaceuticals Inc
All Alnylam Pharmaceuticals Inc insider activity
GET /v1/forms/4/0001178670-26-000087 API docs
View Original SEC Filing